Article
Phosphorylation of the M1 muscarinic acetylcholine receptor mediates protection in neurodegenerative disease
2021-04-29
Abstract excerpt
There are currently no treatments that can slow the progression of neurodegenerative diseases such as Alzheimer’s disease (AD). There is, however, a growing body of evidence that activation of the M1 muscarinic acetylcholine receptor (M1-receptor) can not only restore memory loss in AD patients, but in preclinical animal models can also slow neurodegenerative disease progression. The generation of an effective med...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4e1e5500-88c7-5be2-9808-ec600ef37817
- DOI
- 10.1101/2021.04.29.440753
